CausalSentinel

Protein Dossier — FCGR3B (Low affinity immunoglobulin gamma Fc region receptor III-B)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Ulcerative colitis 0.155 0.0312 6.91e-07 Wald ratio 1 cis NA
Inflammatory bowel disease 0.113 0.0247 4.25e-06 Wald ratio 1 cis NA
Rheumatoid arthritis 0.142 0.0374 1.45e-04 Wald ratio 1 cis NA
Non-cancer illness code self-reported: uterine fibroids -0.216 0.0602 3.32e-04 Wald ratio 1 cis NA
Age at menarche -0.0436 0.0157 0.0053 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hypothyroidism or myxoedema 0.0692 0.0248 0.00531 Wald ratio 1 cis NA
Non-cancer illness code self-reported: asthma 0.0393 0.0161 0.0149 Wald ratio 1 cis NA
Haemoglobin concentration 0.042 0.0179 0.019 Wald ratio 1 cis NA
Total cholesterol 0.0342 0.0147 0.0199 Wald ratio 1 cis NA
Non-cancer illness code self-reported: deep venous thrombosis (dvt) 0.0901 0.0388 0.0203 Wald ratio 1 cis NA
Birth weight -0.0218 0.00942 0.0205 Wald ratio 1 cis NA
Packed cell volume 0.125 0.0547 0.0228 Wald ratio 1 cis NA
…and 93 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3311_27_1 FCG3B Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

151 association rows across 116 traits (150 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating FCGR3B levels 2e-3176 rs1674765 2 GCST90860423 no MR -> candidate analysis
Circulating FCRLB levels 2e-359 rs61803040 1 GCST90860085 no MR -> candidate analysis
Total protein levels (UKB data field 30860) 3e-306 rs2926468 1 GCST90468105 no MR -> candidate analysis
Serum total protein levels 2e-263 rs2926468 2 GCST90018976 no MR -> candidate analysis
FCGR3B protein levels 4e-108 rs61803007 7 GCST90453024 no MR -> candidate analysis
CLEC4A protein levels 1e-82 rs200688856 2 GCST90468771 no MR -> candidate analysis
Aspartate aminotransferase levels (UKB data field 30650) 2e-70 rs61804164 1 GCST90468063 no MR -> candidate analysis
Circulating CLEC4A levels 1e-67 rs505415 1 GCST90860182 no MR -> candidate analysis
PDGFRA protein levels 1e-54 rs61804164 1 GCST90470191 no MR -> candidate analysis
Low affinity immunoglobulin gamma Fc region receptor II-b le 6e-44 rs201117888 1 GCST90241814 no MR -> candidate analysis
Low affinity immunoglobulin gamma Fc region receptor II-b le 1e-43 rs1771575 3 GCST90161704 no MR -> candidate analysis
IgG levels 2e-42 rs72704050 2 GCST008576 no MR -> candidate analysis
…and 104 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 315 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
Oral ulcer 0.538 common-variant locus no MR -> candidate analysis
Takayasu arteritis 0.519 common-variant locus no MR -> candidate analysis
chronic obstructive pulmonary disease 0.433 common-variant locus no MR -> candidate analysis
Erythema nodosum 0.43 common-variant locus no MR -> candidate analysis
rheumatoid arthritis 0.176 common-variant locus MR: beta=0.142, p=1.45e-04 (cis)
limited scleroderma 0.209 common-variant locus no MR -> candidate analysis
hemangioma of subcutaneous tissue 0.209 common-variant locus no MR -> candidate analysis
anti-centromere-antibody-positive systemic scleroderma 0.209 common-variant locus no MR -> candidate analysis
irritable bowel syndrome 0.206 common-variant locus no MR -> candidate analysis
systemic lupus erythematosus 0.039 common-variant locus no MR -> candidate analysis
male reproductive system disorder 0.065 common-variant locus no MR -> candidate analysis
immunoglobulin G4-related sclerosing disease 0.056 common-variant locus no MR -> candidate analysis
heart disorder 0.056 common-variant locus no MR -> candidate analysis

Of the 13 rows above, 12 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Low affinity immunoglobulin gamma Fc region receptor III-B)
gnomAD constraint pLI=6.4e-06, LOEUF=1.09 — LoF-tolerant
GWAS Catalog 198 unique SNPs / 539 rows
ClinVar 82 records; 2 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance